Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway

Authors

Yuman Du
Rui Fan (ORCID: https://orcid.org/0009-0006-0609-5081)
Yong Yang (ORCID: https://orcid.org/0000-0003-3372-071X)
Hairong Wang
Weili Liao
Yuan Tian

Institutions

Yangtze University (CN)
Mudanjiang Medical University (CN)

Publication Details

Journal: Frontiers in Pharmacology
Published: 2026-01-02
DOI: https://doi.org/10.3389/fphar.2025.1764700
Primary Topic: Chronic Kidney Disease and Diabetes
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway

Yuman Du, Rui Fan, Yong Yang, Hairong Wang et al.

Jan 2, 2026

Frontiers in Pharmacology

Chronic Kidney Disease and Diabetes

article

Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway

Yuman Du, Rui Fan, Yong Yang, Hairong Wang, Weili Liao, Yuan Tian

January 2, 2026article en

Abstract

No abstract available for this paper.

Frontiers in PharmacologyVol. 16

Yangtze University (CN), Mudanjiang Medical University (CN)

Openalex Percentile: Top 99%

Chronic Kidney Disease and Diabetes

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway — Yuman Du, Rui Fan, et al. · Frontiers in Pharmacology (2026) | TGRS Research Map | TGRS